Read More

Sera Prognostics Highlights Presentation Of Data Showing Health, Economic Benefit Of Preterm Testing At The Professional Society for Health Economics and Outcomes Research Conference Wednesday, May 18, 2022

 Sera Prognostics Inc., The Pregnancy Company® (NASDAQ:SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today

SERA